Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Coyne

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
International Journal of Nephrology and Renovascular Disease|April 18, 2022
Serum Phosphorus and Pill Burden Among Hemodialysis Patients Prescribed Sucroferric Oxyhydroxide: One-Year Follow-Up on a Contemporary CohortJessica B Kendrick, Meijiao Zhou, Linda H Ficociello, et al.
Frontiers in Child and Adolescent Psychiatry|January 16, 2025
Acceptance and commitment therapy group protocol for caregivers of anxious youth: an open trial pilot studyJacquelyn N Raftery-Helmer, Ashley S Hart, Madeline R Levitt, et al.
Journal of the American Society of Nephrology : JASN|February 3, 2007
Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) StudyDaniel W Coyne, Toros Kapoian, Wadi Suki, et al.
BMC Nephrology|October 31, 2019
Changes in serum albumin and other nutritional markers when using sucroferric oxyhydroxide as phosphate binder among hemodialysis patients: a historical cohort studyKamyar Kalantar-Zadeh, Linda H Ficociello, Vidhya Parameswaran, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 8, 2015
A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemiaPhilip A Kalra, Sunil Bhandari, Sanjiv Saxena, et al.
Cardiorenal Medicine|April 12, 2012
Very Low Density Lipoprotein Metabolism in Patients with Chronic Kidney DiseaseXuewen Wang, Sharina Belani, Daniel W Coyne, et al.
Journal of the American College of Surgeons|October 1, 1996
Comparison of survival of an expanded polytetrafluoroethylene graft designed for early cannulation to standard wall polytetrafluoroethylene graftsD W Coyne, J A Lowell, D W Windus, et al.
Kidney Medicine|August 1, 2020
Sucroferric Oxyhydroxide in Maintenance Hemodialysis: A Retrospective, Comparative Cohort StudyDaniel W Coyne, Linda H Ficociello, Vidhya Parameswaran, et al.
Infection Control and Hospital Epidemiology|October 1, 2010
A crossover intervention trial evaluating the efficacy of a chlorhexidine-impregnated sponge in reducing catheter-related bloodstream infections among patients undergoing hemodialysisBernard C Camins, Amy M Richmond, Kathrin L Dyer, et al.
Journal of the American Society of Nephrology : JASN|December 28, 2014
Considerations and challenges in defining optimal iron utilization in hemodialysisDavid M Charytan, Amy Barton Pai, Christopher T Chan, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
International Journal of Nephrology and Renovascular Disease|April 18, 2022
Serum Phosphorus and Pill Burden Among Hemodialysis Patients Prescribed Sucroferric Oxyhydroxide: One-Year Follow-Up on a Contemporary CohortJessica B Kendrick, Meijiao Zhou, Linda H Ficociello, et al.
Frontiers in Child and Adolescent Psychiatry|January 16, 2025
Acceptance and commitment therapy group protocol for caregivers of anxious youth: an open trial pilot studyJacquelyn N Raftery-Helmer, Ashley S Hart, Madeline R Levitt, et al.
Journal of the American Society of Nephrology : JASN|February 3, 2007
Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) StudyDaniel W Coyne, Toros Kapoian, Wadi Suki, et al.
BMC Nephrology|October 31, 2019
Changes in serum albumin and other nutritional markers when using sucroferric oxyhydroxide as phosphate binder among hemodialysis patients: a historical cohort studyKamyar Kalantar-Zadeh, Linda H Ficociello, Vidhya Parameswaran, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 8, 2015
A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemiaPhilip A Kalra, Sunil Bhandari, Sanjiv Saxena, et al.
Cardiorenal Medicine|April 12, 2012
Very Low Density Lipoprotein Metabolism in Patients with Chronic Kidney DiseaseXuewen Wang, Sharina Belani, Daniel W Coyne, et al.
Journal of the American College of Surgeons|October 1, 1996
Comparison of survival of an expanded polytetrafluoroethylene graft designed for early cannulation to standard wall polytetrafluoroethylene graftsD W Coyne, J A Lowell, D W Windus, et al.
Kidney Medicine|August 1, 2020
Sucroferric Oxyhydroxide in Maintenance Hemodialysis: A Retrospective, Comparative Cohort StudyDaniel W Coyne, Linda H Ficociello, Vidhya Parameswaran, et al.
Infection Control and Hospital Epidemiology|October 1, 2010
A crossover intervention trial evaluating the efficacy of a chlorhexidine-impregnated sponge in reducing catheter-related bloodstream infections among patients undergoing hemodialysisBernard C Camins, Amy M Richmond, Kathrin L Dyer, et al.
Journal of the American Society of Nephrology : JASN|December 28, 2014
Considerations and challenges in defining optimal iron utilization in hemodialysisDavid M Charytan, Amy Barton Pai, Christopher T Chan, et al.
Pageof 10